Review: Production and functionality of active peptides from milk

Food Science and Technology International

Volumn 17, Issue 4, 2011, Pages 293-317

  Muro Urista, C ^a   Alvarez Fernandez R ^b   Riera Rodriguez, F ^b   Arana Cuenca, A ^c   Tellez Jurado A ^c  

^a INSTITUTO TECNOLÓGICO DE TOLUCA   (Mexico)

^b UNIVERSITY OF OVIEDO   (Spain)

^c Universidad Politecnica de Pachuca   (Mexico)

Author keywords

biological activities; milk; Peptides; preclinical studies; whey

Indexed keywords

ACTIVE PEPTIDES; BIOACTIVE PEPTIDES; BIOLOGICAL ACTIVITIES; EXPERIMENTAL ANIMALS; FUNCTIONAL FOODS; INDIVIDUAL PROTEINS; INDUSTRIAL PRODUCTION; MILK; MILK PROTEIN; MILK WHEY; ON-BODY; PHARMACEUTICAL FORMULATION; PHYSIOLOGICAL EFFECTS; POTENTIAL FUNCTIONALITY; PRECLINICAL STUDIES; PROTEIN FRAGMENTS; PROTEIN SOURCES; RESEARCH STUDIES; STRUCTURE IDENTIFICATION; SYNTHETIC PEPTIDE; WHEY;

BIOACTIVITY; DAIRY PRODUCTS; INDUSTRIAL APPLICATIONS; INDUSTRIAL RESEARCH;

PEPTIDES;

ANIMALIA;

CASEIN; MILK PROTEIN; PEPTIDE; PEPTIDE FRAGMENT; PROTEIN HYDROLYSATE; WHEY PROTEIN;

ANIMAL; CHEMISTRY; DAIRY PRODUCT; DRUG DEVELOPMENT; ECONOMICS; FOOD INDUSTRY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MILK; POLLUTION; REVIEW;

ANIMALS; CASEINS; DAIRY PRODUCTS; DRUG DISCOVERY; FOOD-PROCESSING INDUSTRY; HUMANS; MILK; MILK PROTEINS; PEPTIDE FRAGMENTS; PEPTIDES; PROTEIN HYDROLYSATES; WASTE PRODUCTS;

EID: 80052697239     PISSN: 10820132     EISSN: 15321738     Source Type: Journal    
DOI: 10.1177/1082013211398801     Document Type: Review

References (204)

1. Aihara K., Kajimoto O., Hirata H., Takahashi R. and Nakamura Y. (2005). Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. Journal of American College of Nutrition 24 (4). 257-265.
2. Aleixandre A., Miguel M. and Muguerza B. (2008). Péptidos hipertensivos derivados de proteínas de leche y huevo. Nutrición Hospitalaria 23 (4). 313-318. (Pubitemid 352030201)
3. Almaas H., Cases AL, Devold TG, Holm H., Langsrud T., Aabakken L., et al (2006). In vitro digestion of bovine and caprine milk by human gastric and duodenal enzymes. International Dairy Journal 16 (9). 961-968. (Pubitemid 44255681)
4. Miralles B., Krause I., Ramos M. and Amigo L. (2006). Comparison of capillary electrophoresis and isoelectric focusing for analysis of casein/caseinate addition in processed cheese. International Dairy Journal 16 (12). 1448-1453. (Pubitemid 44331596)
5. Andersen ML and Skibsted LH (2006). ESR spectroscopy for the study of oxidative processes in food and beverages. In: Webb GA (ed.) Modern Magnetic Resonance. London: Kluwer Academic Publishers, 1861-1866.
6. Aruoma OI, Deiana M., Jenner A., Halliwell B., Kaur H. and Banni S. (1998). Effect of hydroxytyrosol found in extra virgin olive oil on oxidative DNA damage and on low-density lipoprotein oxidation. Journal of Agricultural Food Chemistry 46 (2). 5181-5187. (Pubitemid 128488279)
7. Ashar MN and Chand R. (2004). Fermented milk containing ACE inhibitory peptides reduces blood pressure in middle-aged hypertensive subjects. Milchwissenschaft-Milk Science International 59 (7-8). 363-366. (Pubitemid 38946885)
8. Baró L., Jiménez J., Martinez A. and Bouza JJ (2001). Bioactive milk peptides and proteins. ARS Pharmaceutica 42 (3-4). 135-145.
9. Batt AC, Brady J. and Sawyer L. (1994). Design improvements of β-lactoglobulin. Trends in Food Science and Technology 5 (8). 261-265.
10. Benzie FF and Strain JJ (1999). The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Analytical Biochemistry 239 (1). 70-76.
11. Boelsma E. and Kloek J. (2009). Lactotripeptides and antihypertensive effects: a critical review. British Journal of Nutrition 101 (6). 776-786.
12. Bouhallab S. and Bougle D. (2004). Biopeptides of milk: caseinophosphopeptides and mineral bioavailability. Reproduction, Nutrition and Development 44 (5). 493-498. (Pubitemid 39618491)
13. Bouhallab S, Cinga V, Ait ON, Bureau F, Neuville D and Arhan P (2002). Continuous hydrolysis of caseinomacropeptide in a membrane reactor: kinetic study and gram-scale production of antithrombotic peptides. Journal of Agricultural and Food Chemistry 50 (3). 7127-7130.
14. Brandelli A., Bizani D., Morrissy AC and Dominguez PM (2008). Inhibition of Listeria monocytogenes in dairy products using the bacteriocin-like peptide cerein 8A. International Journal of Food Microbiology 121 (2). 229-233.
15. Branen J. and Davidson PM (2000). Activity of hydrolysed lactoferrin against food borne pathogenic bacteria in growth media: the effect of EDTA. Letters in Applied Microbiology 30 (3). 233-237. (Pubitemid 30168935)
16. Brody EP (2000). Biological activities of bovine glycomacropeptide. British Journal of Nutrition 84 (1). S39 - S46.
17. Bütikofer U., Meyer J., Sieber R. and Wechsler D. (2007). Quantification of the angiotensin-converting enzyme inhibiting tripeptides Val-Pro-Pro and Ile-Pro-Pro in hard, semi-hard and soft cheese. International Dairy Journal 17 (8). 968-975. (Pubitemid 46551704)
18. Caccavo D., Pellegrino NM, Altamura M., Rigon A., Amati L., Amoroso A., et al (2002). Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application. Endotoxin Research 8 (6). 403-417. (Pubitemid 36104594)
19. Cao G., Sofic E. and Prior R. (1997). Antioxidant and prooxidant behaviour of flavonoids: structure-activity relationships. Free Radical Biology and Medicine 22 (5). 749-760. (Pubitemid 27058337)
20. Careri M. and Mangia A. (2003). Analysis of food proteins and peptides by chromatography and mass spectrometry. Journal of Chromatography A 1000 (1-2). 609-635. (Pubitemid 36638477)
21. Chatterton EW, Smithers G., Roupas P. and Brodkorb A. (2006). Bioactivity of β-lactoglobolin and α-lactalbumin-Technological implications for processing. International Dairy Journal 16 (11). 1229-1240. (Pubitemid 44348873)
22. Cheison SC, Schmitt M., Loeb E., Tetzel T. and Ulrich Kulozik (2010). Influence of temperature and degree of hydrolysis on the peptide composition of trypsin hydrolysates of βlactoglobulin: analysis by LC-ESI-TOF/MS. Food Chemistry 121 (2). 457-467.
23. Cheison SC, Wang Z. and Xu SY (2006). Hydrolysis of whey protein isolate in a tangential flow filter membrane reactor: I. Characterization of permeate flux and product recovery by multivariate data analysis. Journal of Membrane Science 283 (1-2). 45-56. (Pubitemid 44404060)
24. Clare DA, Catignani GL and Swaisgood HE (2003). Biodefense properties of milk: the role of antimicrobial proteins and peptides. Current Pharmaceutical Design 9 (16). 1239-1255. (Pubitemid 36592134)
25. Clare DA and Swaisgood HE (2000). Bioactive milk peptides: a prospectus. Journal of Dairy Science 83 (6). 1187-1195.
26. Collins A. (2005). Antioxidant intervention as a route to cancer prevention. European Journal of Cancer 41 (13). 1923-1930. (Pubitemid 41557678)
27. Cushman DW and Cheung HS (1971). Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochemical Pharmacology 20 (7). 1637-1648.
28. Dávalos A., Miguel M., Bartolomé B. and Lopez-Fandiño R. (2004). Antioxidant activity of peptides derived from egg white proteins by enzymatic hydrolysis. Journal of Food Protection 67 (9). 1939-1944. (Pubitemid 39204664)
29. Decker EA and Welch B. (1990). Role of ferritine as a lipid oxidation catalyst in muscle food. Journal of Agricultural Food Chemistry 38 (3). 674-677.
30. Da Costa EL, JA Da Rocha Montijo and Netto FM (2007). Effect of heat and enzymatic treatment on the antihypertensive activity of whey protein hydrolysates. International Dairy Journal 17 (6). 632-640. (Pubitemid 46290625)
31. De Leeuw PW, Van der Zander K., Kroon AA, Rennenberg RM and Koning MM (2009). Dose dependent lowering of blood pressure by dairy peptides in mildly hypertensive subjects. Blood Pressure 18 (1-2). 44-50.
32. A. De Moreno de LeBlanc, Matar C., Farnworth E. and Perdigón G. (2007). Study of immune cells involved in the antitumour effect of kefir in a murine breast cancer model. Journal of Dairy Science 90 (4). 1920-1928.
33. A. De Moreno de LeBlanc, Matar C., LeBlanc N. and Perdigón G. (2005). Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Research 7 (4). R477 - R486.
34. Del Mar Contreras M., Carrón R., Montero MJ, Ramos M. and Recio I. (2009). Novel casein-derived peptides with antihypertensive activity. International Dairy Journal 19 (10). 566-573.
35. Diaz M. and Decker EA (2004). Antioxidant mechanisms of caseinophosphopeptides and casein hydrolysates and their application in ground beef. Journal of Agricultural and Food Chemistry 52 (26). 8208-8213. (Pubitemid 40053716)
36. Diaz M., Dunn CM, McClements DJ and Decker EA (2003). Use of caseinophosphopeptides as natural antioxidants in oil-in water emulsions. Journal of Agricultural and Food Chemistry 51 (8). 2365-2370.
37. Didelot S., Bordenave JS, Rosenfeld E., Fruitier AI, Piot JM and Sannier F. (2006). Preparation of angiotensin I-converting enzyme inhibitory hydrolysates from unsupplemented caprine whey fermentation by various cheese microflore. International Dairy Journal 16 (9). 976-983. (Pubitemid 44255682)
38. Donkor ON, Henriksson A., Singh KT, Vasiljevic T. and Shah PN (2007). ACE-inhibitory activity of probiotic yoghurt. International Dairy Journal 17 (11). 1321-1331. (Pubitemid 47419318)
39. Dziuba M. and Darewicz M. (2007). Food proteins as precursors of bioactive peptides-classification into families. Food Science and Technology International 13 (6). 393-404. (Pubitemid 351436535)
40. Elias RJ, Kellerby SS and Decker EA (2008). Antioxidant activity of proteins and peptides. Critical Reviews in Food Science and Nutrition 48 (1). 430-441. (Pubitemid 351883136)
41. Ferranti P., Traisci MV, Picariello G., Nasi A., Boschi V. and Siervo M. (2004). Casein proteolysis in human milk: tracing the pattern of casein breakdown and the formation of potential bioactive peptides. Journal of Dairy Research 71 (1). 74-87. (Pubitemid 38370818)
42. Ferreira Implvo, Pinho O., Mota MV, Tavares P., Pereira A., Goncalves MP, et al (2007). Preparation of ingredients containing an ACE inhibitory peptide by tryptic hydrolysis of whey protein concentrates. International Dairy Journal 17 (5). 481-487. (Pubitemid 46043425)
43. FitzGerald RJ (1998). Potential uses of caseinophosphopeptides. International Dairy Journal 8 (5). 451-457.
44. FitzGerald RJ and Murray BA (2006). Bioactive peptides and lactic fermentations. International Journal of Dairy Technology 59 (2). 118-125.
45. FitzGerald RJ, Murray BA and Walsh DJ (2004). Hypotensive peptides from milk proteins. Journal of Nutrition 134 (4). 980S - 988S. (Pubitemid 38456275)
46. Foltz M., Meynen EE, Bianco V., van Platerink C., Koning TM and Klock J. (2007). Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-Enriched milk beverage are absorbed intact into the circulation. Journal of Nutrition 137 (4). 953-958. (Pubitemid 46596893)
47. Friend BA, Farmer RE and Shahani KM (1982). Effect of feeding and intraperitoneal implantation of yogurt culture cells on Ehrlich as cites tumor. Milchwissenschaft-Milk Science International 37 (2). 708-710.
48. Fuglsang A., Rattray FP, Nilsson D. and Nyborg NCB (2003). Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo. Anton Leeuwenhoek 83 (1). 27-34. (Pubitemid 36546318)
49. Gagnaire V., Molle D., Herrouin M. and Leonil J. (2001). Peptides identified during Emmental cheese ripening: origin and proteolytic systems involved. Journal of Agricultural and Food Chemistry 49 (9). 4402-4413. (Pubitemid 32896445)
50. Gauthier SF, Pouliot Y. and Saint-Sauveur D. (2006). Immunomodulatory peptides obtained by the enzymatic hydrolysis of whey proteins. International Dairy Journal 16 (11). 1315-1323. (Pubitemid 44331589)
51. Gill HS, Doull F., Rutherfurd KJ and Cross ML (2000). Immunoregulatory peptides in bovine milk. British Journal of Nutrition 84 (1). 111-117.
52. Gobbetti M., Ferranti P., Smacchi E., Goffredi F. and Addeo F. (2000). Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. Bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Applied and Environmental Microbiology 66 (9). 3898-3904.
53. Gobbetti M., Minervini F. and Rizzello CG (2004). Angiotensin I converting-enzyme-inhibitory and antimicrobial bioactive peptides. International Journal of Dairy Technology 57 (2-3). 172-188.
54. Gobbetti M., Minervini F. and Rizzello CG (2007). Bioactive peptides in dairy products. In: Hui YH (ed.) Handbook of Food Products Manufacturing. Hoboken, NJ: John Wiley & Sons, Inc, 489-517.
55. Gómez-Ruiz JA, Ramos M. and Recio I. (2002). Angiotensin converting enzyme-inhibitory peptides in Manchego cheese manufactured with different starter cultures. International Dairy Journal 12 (8). 697-706.
56. Guo Y., Pan D. and Tanokura M. (2004). Antihypertensive peptides from skimmed milk hydrolysate digested by cell-free extract of Lactobacillus helveticus JCM1004. Food Chemistry 91 (1). 123-129. (Pubitemid 39572541)
57. Halliwell B. and Whiteman M. (2004). Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean. British Journal of Pharmacology 142 (2). 231-255. (Pubitemid 38746160)
58. Haque E., Chand R. and Kapila S. (2009). Biofunctional properties of bioactive peptides of milk origin. Food Reviews International 25 (1). 28-43.
59. Hartmann R. and Meisel H. (2007). Food-derived peptides with biological activity: from research to food applications. Current Opinion in Biotechnology 18 (2). 163-169. (Pubitemid 46575225)
60. Haug A., Hostmark AT and Harstad OM (2007). Bovine milk in human nutrition-a review. Lipids Health and Disease 6 (25). 1-25.
61. Hernández-Ledesma B., Amigo L., Ramos M. and Recio I. (2004 a). Angiotensin converting enzyme inhibitory activity in commercial fermented products. Formation of peptides under simulated gastrointestinal digestion. Journal of Agricultural and Food Chemistry 52 (6). 1504-1510.
62. Hernández-Ledesma B., Amigo L., Ramos M. and Recio I. (2004 b). Release of angiotensin converting enzyme-inhibitory peptides by simulated gastrointestinal digestion of infant formulas. International Dairy Journal 14 (10). 889-898. (Pubitemid 39081556)
63. Hernández-Ledesma B., Miguel M., Amigo L., Aleixandre MA and Recio I. (2007). Effect of simulated gastrointestinal digestion on the antihypertensive properties of lactoglobulin peptides. Journal of Dairy Research 74 (3). 336-339. (Pubitemid 47580836)
64. Hernández-Ledesma B., Recio I., Ramos M. and Amigo L. (2002). Preparation of ovine and caprine-lactoglobulin hydrolysates with ACE-inhibitory activity. Identification of active peptides from caprine-lactoglobulin hydrolyzed with thermolysin. International Dairy Journal 12 (10). 805-812. (Pubitemid 35169483)
65. Hirota T., Ohki K., Kawagishi R., Kajimoto Y., Mizuno S. and Nakamura Y. (2007). Casein hydrolysate containing the antihypertensive tri-peptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin converting enzyme. Hypertension Research 30 (6). 489-496. (Pubitemid 47083118)
66. Hoelzl C., Bichler J., Ferk F., Simic T., Nersesyan A. and Elbling L. (2005). Methods for the detection of antioxidants which prevent age related diseases: a critical review with particular emphasis on human intervention studies. Journal of Physiology and Pharmacology 56 (2). 49-64. (Pubitemid 44933668)
67. Hori T., Kiyoshima J., Shida K. and Yasui H. (2002). Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clinical and Diagnostic Laboratory Immunology 9 (1). 105-108. (Pubitemid 34084284)
68. Hu C. and Kitts DD (2001). Evaluation of antioxidant activity of epigallocatechin gallate in biphasic model systems in vitro. Molecular and Cellular Biochemistry 218 (1-2). 147-155. (Pubitemid 32294145)
69. Huttunen M., Pekkinen M., Alström MEB and Lamberg-Allardt CJE (2007). Effects of bioactive peptides isoleucine-proline-proline (IPP), vaine-porline-proline (VPP) and leucine-lysine-proline (LKP) on gene expression of osteoblasts differentiated from human mesenhymal stem cells. British Journal of Nutrition 98 (4). 780-788. (Pubitemid 47487945)
70. Hyun CK and Shin HK (2000). Utilization of bovine blood plasma proteins for the production of angiotensin I converting enzyme inhibitory peptides. Process Biochemistry 36 (1-2). 65-71.
71. Jäkälä P., Hakala A., Turpeinen A., Korpela R. and Vapaatalo H. (2009). Casein-derived Ile-Pro-Pro and Val-Pro-Pro attenuate the development of hypertension and improve endothelial function in salt-loaded Goto-Kakizaki rats. Journal Functional Foods 1 (4). 366-374.
72. Jäkälä P. and Vapaatalo H. (2010). Antihypertensive Peptides from Milk Proteins. Pharmaceuticals 3 (1). 251-272.
73. Kanamori Y., Sugiyama M., Hashizume K., Yuki N., Morotomi M. and Tanaka R. (2004). Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. Journal of Pediatric Surgery 39 (11). 1686-1692. (Pubitemid 39488000)
74. Kanazawa H., Nagino M., Kamiya S., Komatsu S., Mayumi T., Takagi K., et al (2005). Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbeck's Archives of Surgery 390 (2). 104-113. (Pubitemid 40487433)
75. Kilara A. and Panyam D. (2003). Peptides from milk proteins and their properties. Critical reviews. Food Science and Nutrition 43 (6). 607-633. (Pubitemid 38552292)
76. Kim SY, Je JY and Kim SK (2007). Purification and characterization of antioxidant peptide from hoki (Johnius belengerii) frame protein by gastrointestinal digestion. Journal of Nutritional Biochemistry 18 (1). 31-38.
77. Kitts DD (2005). Antioxidant properties of casein-phosphopeptides. Trends in Food Science and Technology 16 (12). 549-554.
78. Kitts DD and Weiler K. (2003). Bioactive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Current Pharmaceutical Design 9 (16). 1309-1323. (Pubitemid 36592139)
79. Koebnick C., Wagner I., Leitzmann P., Stern U. and Zunft HJ (2003). Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Canadian Journal of Gastroenterology 17 (11). 655-659. (Pubitemid 37536846)
80. Korhonen H. (2009). Milk-derived bioactive peptides: from science to applications. Journal of Functional Foods 1 (2). 177-187.
81. Korhonen H. and Pihlanto LA (2001). Milk protein-derived bioactive peptides-novel opportunities for health promotion. IDF Bulletin 363 (7). 17-26.
82. Korhonen H. and Pihlanto A. (2003). Food-derived bioactive peptides-opportunities for designing future foods. Current Pharmaceutical Design 9 (16). 1297-1308. (Pubitemid 36592138)
83. Korhonen H. and Pihlanto A. (2006). Bioactive peptides: production and functionality. International Dairy Journal 16 (9). 945-960. (Pubitemid 44255683)
84. Korhonen H. and Pihlanto A. (2007 a). Bioactive peptides from food proteins. In: Hui YH (ed.) Handbook of Food Products Manufacturing. Hoboken, NJ: John Wiley and Sons Inc., 5-37.
85. Korhonen H. and Pihlanto A. (2007 b). Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Current Pharmaceutical Design 13 (8). 829-843. (Pubitemid 46591100)
86. Kudoh Y., Matsuda S., Igoshi K. and Oki T. (2001). Antioxidative peptide from milk fermented with Lactobacillus delbrueckii subsp. bulgaricus IFO13953. Journal Nippon Shokuhin Kagaku Kogaku Kaishi 48 (1). 44-50.
87. Lehtinen R., Jauhiainen T., Kankuri E., Lindstedt K., Kovanen PT, Kerojoki O., et al (2010). Effects of milk casein-derived tripeptides Ile-Pro-Pro, Val-Pro-Pro, and Leu-Pro-Pro on enzymes processing vasoactive precursors in vitro. Arzneimittel Forschung-Drug Research 60 (4). 182-185.
88. Leporanta K. (2001). Developing fermented milks into functional foods. Innovation Food Technology 10 (1). 46-47.
89. Li G., Le G., Shi Y. and Shrestha S. (2004). Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutrition Research 24 (7). 469-486. (Pubitemid 38968489)
90. Li EWY and Mine Y. (2004). Immunoenhancing effects of bovine glycomacropeptide and its derivatives on the proliferative response and phagocytic activities of human macrophage like cells, U937. Journal of Agricultural and Food Chemistry 52 (9). 2704-2708.
91. Li Chen T., Chie Lo Y., Tze Hu W., Chang Wu M., Ten Chen S. and Min Chang H. (2003). Microencapsulation and modification of synthetic peptides of food proteins reduces the blood pressure of spontaneously hypertensive rats. Journal of Agricultural and Food Chemistry 51 (6). 1671-1675.
92. López-Expósito R., Gómez GA, Amigo L. and Recio I. (2006 a). Identification of antibacterial peptides from ovine αs2-casein. International Dairy Journal 16 (9). 1072-1080.
93. López-Expósito R., Otte J. and Camp JV (2006 b). Physiological, chemical and technological aspects of milk-protein-derived peptides with antihypertensive and ACE-inhibitory activity. International Dairy Journal 16 (11). 1277-1293.
94. López-Expósito R. and Ramos R. (1992). Revisión: caseinomacropéptido bovino. Características físico- químicas y actividad biológica. Revista Española de Ciencia y Tecnología de Alimentos 32 (6). 575-588.
95. López-Expósito R. and Recio I. (2006). Antibacterial activity of peptides and folding variants from milk proteins. International Dairy Journal 16 (11). 1294-1305. (Pubitemid 44339601)
96. López-Expósito R. and Recio I. (2008). Protective effect of milk peptides: antibacterial and antitumor properties. In: Bösze Z (ed.) Advances in Experimental Medicine and Biology: Bioactive Components of Milk. New York: Springer Science, 271-294.
97. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951). Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 193 (1). 265-275.
98. Madureira RA, Pereira IC, Gómez PA, Pintado EM and Malcata FX (2007). Bovine whey proteins-Overview on their main biological properties. Food Research International 40 (10). 1197-1211.
99. Maes W., Van Camp J., Vermeirssen V., Hemeryck M., Ketelslegers JM, Schrezenmeier J., et al (2004). Influence of the lactokinin Ala-Leu- Pro-Met-His-Ile-Arg (ALPMHIR) on the release of endothelin-1 by endothelial cells. Regulatory Peptides 118 (1-2). 105-109. (Pubitemid 38167372)
100. Mahmud R., Matn MA and Otani H. (2004). Mitogenic effect of bovine b-lactoglobulin and its proteolytic digests on mouse spleen resting cells. Pakistan Journal of Biological Sciences 7 (12). 2045-2050.
101. Malkoski M., Dashper SG, O'Brien NM, Talbo GH, Macris M. and Cross KJ (2001). Kappacin, a novel antibacterial peptide from bovine milk. Antimicrobial Agents in Chemotherapy 45 (8). 2309-2315. (Pubitemid 32664472)
102. Mamone G., Picariello G., Caira S., Addeo F. and Ferranti P. (2009). Analysis of food proteins and peptides by mass spectrometry-based techniques. Journal of Chromatography A 1216 (43). 7130-7142.
103. Manso A. and López FR (2003). Angiotensin I converting enzyme-inhibitory activity of bovine; ovine; and caprine kappa-casein macropeptides and their tryptic hydrolysates. Journal of Food Protection 66 (9). 1686-1692.
104. Manso MA and López-Fandiño R. (2004). k-Casein macropeptides from cheese whey: physicochemical, biological, nutritional and technological features for possible uses. Food Reviews International 20 (2). 329-355. (Pubitemid 39616892)
105. Mao XY, Ni JR, Sun LW, Hao PP and Fan L. (2007). Value-added utilization of yak milk casein for the production of angiotensin-I-converting enzyme inhibitory peptides. Food Chemistry 103 (4). 1282-1287. (Pubitemid 46467120)
106. Marshall K. (2004). Therapeutic applications of whey protein. Alternative Medicine Review 9 (2). 136-156. (Pubitemid 38821803)
107. Matar C., LeBlanc JG, Martin L. and Perdigón G. (2003). Biologically active peptides released in fermented milk: role and functions. In: Farnworth ER (ed.) Handbook of Fermented Functional Foods. Functional Foods and Nutraceuticals Series. Boca Raton, FL: CRC Press, 177-201.
108. Matar C., Valdez JC, Medina M., Rachid M. and Perdigón G. (2001). Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. Journal of Dairy Research 68 (4). 601-609. (Pubitemid 33699502)
109. Matsumoto S., Hara T., Hori T., Mitsuyama K., Nagaoka M., Tomiyasu N., et al (2005). Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of proinflammatory cytokines in lamina propria mononuclear cells. Clinical and Experimental Immunology 140 (3). 417-426. (Pubitemid 40813951)
110. Matsumoto K., Takada T., Shimizu K., Kado Y., Kawakami K., Makino I., et al (2006). The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microflora of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Bioscience and Microflora 25 (2). 39-48.
111. Matsuzaki T., Matsuzaki T., Yokokura T. and Mutai M. (1988 b). Antitumor effect of intrapleural administration of Lactobacillus casei in mice. Cancer Immunology Immunotherapy 26 (3). 209-214.
112. Matsuzaki T., Nagata Y., Kado S., Uchida K., Kato I., Hashimoto S., et al (1997). Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. APMIS 105 (7-12). 643-649. (Pubitemid 27380828)
113. Matsuzaki T., Tsukio K., Yokokura T. and Mutai M. (1988 a). Effect of subcutaneous injection of a lactobacilli preparation, LC9018 and antitumor drugs on murine tumor. Biotherapy 2 (3). 440-445.
114. McCann KB, Shiell BJ, Michalski WP, Lee A., Wan J. and Roginski H. (2005). Isolation and characterization of antibacterial peptides derived from the f(164-207) region of bovine αS2-casein. International Dairy Journal 15 (12). 133-143. (Pubitemid 40084662)
115. Megías C., Pedroche J., Yust MM, Alaiz M., Girón CJ, Millán F., et al (2009). Purification of angiotensin converting enzyme inhibitory peptides from sunflower protein hydrolysates by reverse-phase chromatography following affinity purification. Food Science and Technology 42 (1). 228-232.
116. Meisel H. (2001). Bioactive peptides from milk proteins: a perspective for consumers and producers. Australian Journal of Dairy Technology 56 (2). 83-92.
117. Meisel H. (2004). Multifunctional peptides encrypted in milk proteins. BioFactors 21 (1-4). 55-61. (Pubitemid 40921826)
118. Meisel H. (2005). Biochemical properties of peptides encrypted in bovine milk proteins. Current Medicinal Chemistry 12 (16). 1905-1919. (Pubitemid 41015186)
119. Meisel H., Bernard H., Fairweather-Tait S., FitzGerald RJ, Hartmann R. and Lane CN (2003). Detection of caseinophosphopeptides in the distal ileostomy fluid of human subjects. British Journal of Nutrition 89 (3). 351-358. (Pubitemid 36422776)
120. Meisel H. and Bockelmann W. (1999). Bioactive peptides encrypted in milk proteins: proteolytic activation and trophy-functional properties. Antoine van Leeuwenhoek 76 (1-4). 207-215. (Pubitemid 29440728)
121. Meisel H. and FitzGerald RJ (2003). Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Current Pharmaceutical Design 9 (16). 1289-1295. (Pubitemid 36592137)
122. Meisel H. and FitzGerald RJ (2004). Opioid peptides encrypted in intact milk protein sequences. British Journal of Nutrition 84 (1). 27-31.
123. Meisel H., Walsh DJ, Murray BA and FitzGerald RJ (2006). ACE inhibitory peptides. In: Mine Y and Shahidi F (eds) Nutraceutical Proteins and Peptides in Health and Disease. Nutraceutical Science and Technology. New York: CRC Press, Taylor and Francis Group, 269-315.
124. Mercier A., Gauthier SF and Fliss I. (2004). Immunomodulating effects of whey proteins and their enzymatic digests. International Dairy Journal 14 (3). 175-183. (Pubitemid 38203932)
125. Miguel M., Contreras MM, Aleixandre A. and Recio I. (2009). ACE-inhibitory and antihypertensive properties of a bovine casein hydrolysate. Food Chemistry 112 (1). 211-214.
126. Miguel M., Manso MA, López R., Alonso MJ and Salaices M. (2007). Effects and antihypertensive properties of K-casein macro peptide. International Dairy Journal 17 (12). 1473-1477. (Pubitemid 47380328)
127. Miguel M., Muguerza B., Sánchez E., Delgado MA, Recio I., Ramos M., et al (2005). Changes in arterial blood pressure of milk fermented by Enterococcus faecalis CECT 5728 spontaneously hypertensive rats. British Nutritional Journal 93 (1). 1-9.
128. Minkiewicz P., Dziuba J., Iwaniak A., Dziuba M. and Darewicz M. (2008). BIOPEP database and other programs for processing bioactive peptide sequences. Journal of AOAC International 91 (4). 965-980.
129. Miralles B., Krause I., Ramos M. and Amigo L. (2006). Comparison of capillary electrophoresis and isoelectric for analysis of casein/caseinate addition in processed cheese. International Dairy Journal 16: 1448-1453. (Pubitemid 44331596)
130. Miyazaki K. and Matsuzaki T. (2008). Health properties of milk fermented with Lactobacillus casei strain Shirota (LcS). In: Farnworth ER (ed.) Handbook of Fermented Functional Foods, 2nd Edition. New York: CRC Press, Taylor and Francis Group, 165-208.
131. Miz-uno S., Matsuura K., Gotou T., Nishimura S., Kajimoto O., Yabune M., et al (2005). Antihypertensive effect of casein hydrolysate in a placebocontrolled study in subjects with high normal blood pressure and mild hypertension. British Journal of Nutrition 94 (1). 84-91. (Pubitemid 41357814)
132. Moller P. and Loft S. (2002). Oxidative DNA damage in human white blood cells in dietary antioxidant intervention studies. American Journal of Clinical Nutrition 76 (2). 303-310. (Pubitemid 34804049)
133. Mullaly MM, Meisel H. and FitzGerald RJ (1996). Synthetic peptides corresponding to α-lactalbumin and β-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biological Chemistry Hoppe-Seyler 377 (4). 259-260.
134. Murray BA and FitzGerald RJ (2007). Angiotensin converting enzyme inhibitory peptides derived from food proteins: biochemistry, bioactivity and production. Current Pharmaceutical Design 13 (8). 773-791. (Pubitemid 46591099)
135. Nielsen SM, Martinussen T., Flambard B., Sørensen IK and Otte J. (2009). Peptide profiles and angiotensin-I-converting enzyme inhibitory activity of fermented milk products: effect of bacterial strain, fermentation pH and storage time. International Dairy Journal 19 (3). 155-165.
136. Nurminen ML, Sipola M., Kaarto H., Pihlanto-Leppälä A., Piilola K. and Korpela R. (2000). α-Lactorphin lowers blood pressure via radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sciences 66 (16). 1535-1543. (Pubitemid 30155383)
137. Ogawa M., Shimizu K., Nomoto K., Takahashi M., Watanuki M., Tanaka R., et al (2001). Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits. Infection and Immunity 69 (2). 1101-1108. (Pubitemid 32109578)
138. Omata Y., Satake M., Maeda R., Saito A., Shimazaki K. and Yamauchi K. (2001). Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedai sporozoites by treatment with bovine lactoferricin. Journal of Veterinary Medical Science 63 (2). 187-190. (Pubitemid 33674513)
139. Orsi N. (2004). The antimicrobial activity of lactoferrin: current status and perspectives. BioMetals 17 (3). 189-196. (Pubitemid 38987136)
140. Ortiz P., Gómez JA, Rastall RA, Mills D., Cramer R., Pihlanto A., et al (2009). Production of novel ACE inhibitory peptides from β-lactoglobulin usin Protease N Amano. International Dairy Journal 19 (2). 69-76.
141. Otte J., Samah Shalaby MA, Zakora M. and Nielsen MS (2007 c). Fractionation and identification of ACE-inhibitory peptides from á-lactalbumin and ĝ-casein produced by thermolysin-catalysed hydrolysis. International Dairy Journal 17 (6). 1460-1472. (Pubitemid 47380325)
142. Otte J., Shalaby SM, Zakora M. and Nielsen SM (2007 a). Fractionation and identification of ACE-inhibitory peptides from α-lactalbumin and β-casein produced by thermolysin-catalysed hydrolysis. International Dairy Journal 17 (12). 1460-1472. (Pubitemid 47380325)
143. Otte J., Shalaby SM, Zakora M., Prippa AH and Shabrawyb SA (2007 b). Angiotensin-converting enzyme inhibitory activity of milk protein hydrolysates: effect of substrate, enzyme and time of hydrolysis. International Dairy Journal 17 (5). 488-503. (Pubitemid 46043426)
144. Ounis BW, Champagne PC, Makhlouf J. and Bazinet L. (2008). Utilization of tofu whey pre-treated by electro-membrane process as a growth medium for Lactobacillus plantarum LB17. Desalination 229 (1-3). 192-203. (Pubitemid 351927746)
145. Packard RRS and Libby P. (2008). Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clinical Chemistry 54 (10). 24-38. (Pubitemid 351182593)
146. Pan D., Luo Y. and Tanokura M. (2004). Antihypertensive peptides from skimmed milk hydrolysate digested by cell free extract of Lactobacillus helveticus JCM1004. Food Chemistry 91 (16). 123-129. (Pubitemid 39572541)
147. Pellegrini A. (2003). Antimicrobial peptides from food proteins. Current Pharmaceutical Design 9 (1). 1225-1238. (Pubitemid 36592133)
148. Pellegrini A., Dettling C., Thomas U. and Hunziker P. (2001). Isolation and characterization of four bactericidal domains in the bovine β-lactoglobulin. Biochimica et Biophysica Acta 1526 (2). 131-140. (Pubitemid 32452248)
149. Peña RE and Xiong YL (2001). Antioxidative activity of whey protein hydrolysates in a liposomal system. Journal of Dairy Science 84 (12). 2577-2583. (Pubitemid 33609741)
150. Peña RE and Xiong YL (2003). Whey and soy protein hydrolysates inhibit lipid oxidation in cooked pork patties. Meat Science 64 (3). 259-263.
151. Peng J., Tang CE, Zhen WD and Chen Z. (2009). Physicochemical and antioxidant properties of buckwheat (Fagopyrum esculentum Moench) protein hydrolysates. Food Chemistry 115 (2). 672-678.
152. Perdigón G., Fuller R. and Raya R. (2001). Lactic acid bacteria and their effect on the immune system. Current Issues in Intestinal Microbiology 2 (1). 27-42. (Pubitemid 32401085)
153. Perdigón G., Valdez JC and Rachid M. (1998). Antitumour activity of yogurt: study of possible immune mechanisms. Journal of Dairy Research 65 (1). 129-138. (Pubitemid 28139776)
154. Phelan M., Aherne A., FitzGerald RJ and O'Brien NM (2009 a). Casein-derived Bioactive Peptides: biological effects, industrial uses, safety aspects, and regulatory status: a review. International Dairy Journal 19 (11). 643-654.
155. Phelan SM, Aherne BA, O'Sullivan D., FitzGerald JR and O'Brien MN (2009 b). Potential bioactive effects of casein hydrolysates on human cultured cells. International Dairy Journal 19 (5). 279-285.
156. Phelan M., Aherne SA, O'Sullivan D., FitzGerald RJ and O'Brien NM (2010). Growth inhibitory effects of casein hydrolysates on human cancer cell lines. Journal of Dairy Research 77 (2). 1-7.
157. Pihlanto A. (2006). Review: antioxidative peptides derived from milk proteins. International Dairy Journal 16 (11). 1306-1314. (Pubitemid 44331582)
158. Pihlanto A. and Korhonen H. (2003). Bioactive peptides and proteins. Advances in Food and Nutrition Research 47 (4). 175-276. (Pubitemid 137640846)
159. Pihlanto-Leppälä A. (2001). Bioactive peptides derived from bovine whey proteins: opioid and ACE-inhibitory peptides. Trends in Food Science and Technology 11 (9-10). 347-356. (Pubitemid 32516037)
160. Pihlanto-Leppälä A., Koskinen P., Piilola K., Tupasela T. and Korhonen H. (2000). Angiotensin I-converting enzyme inhibitory properties of whey protein digests: concentration and characterization of active peptides. Journal of Dairy Research 67 (1). 53-64. (Pubitemid 30104846)
161. Quirós A., Hernandez-Ledesma B., Ramos M., Amigo L. and Recio I. (2005). Angiotensin-converting enzyme inhibitory activity of peptides derived from caprine kefir. Journal of Dairy Science 88 (10). 3480-3487. (Pubitemid 41624074)
162. Quirós A., Ramos M., Muguerza B., Delgado MA, Miguel M., Aleixandre MA and Recio I. (2007). Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. International Dairy Journal 17 (1). 33-41. (Pubitemid 46070165)
163. Rival SG, Boeriu CG and Wichers HJ (2001). Caseins and casein hydrolysates. 2. Antioxidative properties and relevance to lipoxygenase inhibition. Journal of Agricultural and Food Chemistry 4 (1). 295-302. (Pubitemid 32104525)
164. Roufik S., Gauthier SF and Turgeon SL (2006). In vitro digestibility of bioactive peptides derived from bovine β-lactoglobulin. International Dairy Journal 16 (4). 294-302. (Pubitemid 43061178)
165. Ruiz P., Burguete CM, Castelló M., Marcos JF, Salom JB, Vallés S., et al (2007). Bovine lactoferrin pepsin hydrolysate exerts hinhibytore effect on angiotensin I-converting enzyme-dependent vasoconstriction. International Dairy Journal 17 (10). 1212-1215. (Pubitemid 47095289)
166. Ryhänen EL, Pihlanto LA and Pahkala E. (2001). A new type of ripened; low-fat cheese with bioactive properties. International Dairy Journal 11 (4-7). 441-447. (Pubitemid 32752183)
167. Saikali J., Picard C., Freitas M. and Holt P. (2004). Fermented milks, probiotic cultures, and colon cancer. Nutrition and Cancer 49 (1). 14-24. (Pubitemid 39299122)
168. Saito T. (2008). Antihypertensive peptides derived from bovine casein and whey proteins. In: Bösze Z (ed.) Advances in Experimental Medicine and Biology: Bioactive Components of Milk. New York: Springer, 295-317.
169. Saito R., Nakamura T., Kitazawa H., Kawai Y. and Itoh T. (2000). Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese. Journal of Dairy Science 83 (7). 1434-1440.
170. Sakanaka S., Tachibana Y., Ishihara N. and Juneja LR (2005). Antioxidant properties of casein calcium peptides and their effects on lipid oxidation in beef homogenates. Journal of Agricultural and Food Chemistry 53 (2). 464-468. (Pubitemid 40129942)
171. Saxena A., Tripathi BP, Kumar M. and Shahi VK (2009). Membrane-based techniques for the separation and purification of proteins: an overview. Advances in Colloid and Interface Science 145 (1-2). 1-22.
172. Seppo L., Jauhiainen T., Poussa T. and Korpela R. (2003). A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. American Journal of Clinical Nutrition 77 (2). 326-330. (Pubitemid 36133373)
173. Shimizu M. (2004). Food-derived peptides and intestinal functions. BioFactors 21 (1-2). 43-47. (Pubitemid 40921824)
174. Sienkiewicz-Szapka E., Jarmołowska B., Krawczuk S., Kostyra E., Kostyra H. and Iwan M. (2009). Contents of agonistic and antagonistic opioid peptides in different cheese varieties. International Dairy Journal 19 (4). 258-263.
175. Silva SV and Malcata FX (2005). Caseins as source of bioactive peptides. International Dairy Journal 15 (1). 1-15. (Pubitemid 39527112)
176. Simone CD, Picariello G., Mamone G., Stiuso P., Dicitore A., Vanacore D., et al (2009). Characterization and cytomodulatory properties of peptides from Mozzarella di Bufala Campana cheese whey. Journal of Peptide Science 15 (3). 251-258.
177. Sinha PR, Rahda C., Prakash J. and Kaul P. (2007). Whey protein hydrolysate: functional properties nutritional quality and utilization in beverage formulation. Food Chemistry 101 (4). 1484-1491. (Pubitemid 44466234)
178. Sipola M., Finckenberg P., Korpela R., Vapaatalo H. and Nurminen MA (2002). Effect of long-term intake of milk products on blood pressure in hypertensive rats. Dairy Research Journal 69 (1). 103-111. (Pubitemid 34544013)
179. Sipola M., Finckenberg P., Santisteban J., Korpela R., Vapaatalo H. and Nurminen MA (2001). Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. Physics Pharmacy Journal 52 (4). 745-754. (Pubitemid 34042359)
180. Smacchi E. and Gobbetti M. (2000). Bioactive peptides in dairy products: synthesis and interaction with proteolytic enzymes. Food Microbiology 17 (2). 129-141.
181. Smithers WG (2008). Whey and whey proteins-From 'gutterto-gold'. International Dairy Journal 18 (7). 695-704.
182. Sugawara G., Nagino M., Arai T., Nishio H., Ebata T. and Takagi K. (2006). Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Annals of Surgery 244 (5). 706-714. (Pubitemid 44629944)
183. Takano T. (2002). Anti-hypertensive activity of fermented dairy products containing biogenic peptides. Antoine van Leeuwenhoek 82 (1). 333-340.
184. Tauzin J., Miclo L. and Gaillard J. (2002). Angiotensin I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine casein. FEBS Letters 531 (2). 369-374. (Pubitemid 35341226)
185. Teschemacher H. (2003). Opioid receptor ligands derived from food proteins. Current Pharmaceutical Design 9 (16). 1331-1344. (Pubitemid 36592141)
186. Tolkarach A. and Kulozik U. (2004). Fractionation of whey proteins and peptides by means of membrane techniques in connection with chemical and physical pretreatments. IDF Bulletin 389: 20-23.
187. Tolkarach A. and Kulozik U. (2005). Fractionation of whey proteins and caseinomacropeptide by means of enzymatic cross linking and membrane separation techniques. Journal of Food Engineering 67 (1-2). 13-20.
188. Townsend RR, McFadden CB, Ford V. and Cadeé JA (2004). A randomized, doubled-blind, placebo controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. American Journal of Hypertension 17 (11). 1056-1058. (Pubitemid 39469330)
189. Tsai YT, Cheng PC, Fan CK and Pan TM (2008). Antihypertensive effect of bioactive peptides produced by protease-facilitated lactic acid fermentation of milk. Food Chemistry 106 (2). 552-558.
190. Ueno K., Mizuno K. and Yamamoto N. (2004). Purification and characterization of an endopeptidase that has an important role in the carboxyl terminal processing of antihypertensive peptides in Lactobacillus helveticus CM4. Letters in Applied Microbiology 39 (4). 313-318. (Pubitemid 39331559)
191. Van der Zander K., Bots ML, Bak AAA, Koning MMG and De Leeuw PW (2008). Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. American Journal of Clinical Nutrition 88 (6). 1697-1702.
192. Van Mierlo LAJ, Koning MMG, Van der Zander K. and Draijer R. (2009). Lactotripeptides do not lower blood pressure in untreated whites: results from 2 controlled multicenter crossover studies. American Journal of Clinical Nutrition 89 (2). 617-623.
193. Vermeirssen V., Van Camp J. and Verstraete W. (2004). Bioavailability of angiotensin I-converting enzyme inhibitory peptides. British Journal of Nutrition 92 (3). 357-366. (Pubitemid 40277058)
194. Vinderola G., A. De Moreno de LeBlanc, Perdigón G. and Matar C. (2008). Biologically active peptides released in fermented milk: role and functions. In: Farnworth ER (ed.) Handbook of Fermented Functional Foods. Boca Raton, FL: CRC press, 209-242.
195. Vinderola G., Matar C., Palacios J. and Perdigón G. (2007). Mucosal immunomodulation by the non-bacterial fraction of milk fermented by Lactobacillus helveticus R389. International Journal Food Microbiology 115 (2). 180-186. (Pubitemid 46367331)
196. Virtanen T., Pihlanto A., Akkanen S. and Korhonen H. (2006). Development of antioxidant activity in milk whey during fermentation with lactic acid bacteria. Journal of Applied Microbiology 102 (1). 106-115.
197. Wang ChK, Cadée J., Chang Ch, Chien Ch, Huang Ch and Chen S. (2007). Bovine casein hydrolysate (C12 peptide) reduces blood pressure in prehypertensive subjects. American Journal of Hypertension 20 (1). 1-5. (Pubitemid 46014060)
198. Wu J. and Ding X. (2002). Characterization of inhibition and stability of soy-protein-derived angiotensin I-converting enzyme inhibitory peptides. Food Research International 35 (4). 367-375. (Pubitemid 34294400)
199. Xu JY, Qin LQ, Wang PY, Li W. and Chang C. (2008). Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 24 (10). 933-940.
200. Yamaguchi N., Kawaguchi K. and Yamamoto N. (2009). Study of the mechanism of antihypertensive peptide VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis. European Journal Pharmacology 620 (1-2). 71-77.
201. Yamamoto N., Ejiri M. and Mizuno S. (2003). Biogenic peptides and their potential use. Current Pharmaceutical Design 9 (16). 1345-1355. (Pubitemid 36592142)
202. Yamaoka H., Akedo I., Otani T., Suzuki T., Nakamura T., Takeyama I., et al (2005). Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. International Journal of Cancer 116 (5). 762-767. (Pubitemid 41099707)
203. Yasui H., Kiyoshima J. and Hori T. (2004). Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clinical and Diagnostic Laboratory Immunology 11 (4). 675-679. (Pubitemid 38943988)
204. Zhang G., Li W., Holle L., Chen N. and Chen WY (2002). A novel design of targeted endocrine and cytokine therapy for breast cancer. Clinical Cancer Research 8 (4). 1196-1205. (Pubitemid 35177375)